Linezolid-induced neuropathy [5]

Clinical Infectious Diseases

Volumn 38, Issue 5, 2004, Pages 767-768

  Legout, L ^a,b   Senneville, E ^a   Gomel, J J ^a   Yazdanpanah, Y ^a   Mouton, Y ^a  

^a Dron Hospital   (France)

^b Hopital Dron   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; CLINDAMYCIN; LEVOFLOXACIN; LINEZOLID; PENICILLIN G; ROXITROMYCIN; UNCLASSIFIED DRUG; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; OXAZOLIDINONE DERIVATIVE;

ABSCESS; ADULT; ANAMNESIS; BONE MARROW SUPPRESSION; CASE REPORT; CHRONIC DISEASE; DIAGNOSTIC PROCEDURE; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FEMALE; HAND INJURY; HUMAN; LETTER; NEUROPATHY; PARESTHESIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER; NOTE; PERIPHERAL NEUROPATHY;

ACETAMIDES; ADULT; ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; OXAZOLIDINONES; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 1442278292     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/381762     Document Type: Letter

References (6)

1. Lee E, Burger S, Shah J, et al. Linezolid-associated toxic optic neuropathy: a report of 2 cases. Clin Infect Dis 2003; 37:1389-91.
2. Rana B, Butcher I, Grigoris P, Murnaghan C, Seaton RA, Tobin CM. Linezolid penetration into osteo-articular tissues. J Antimicrob Chemother 2002; 50:747-50.
3. Brown-Elliott BA, Shelby CW, Crist CJ, Mann LB, Wilson RW, Wallace RJ. In vitro activities of linezolid against multiple Nocardia species. Antimicrob Agents Chemother 2001; 45:1295-7.
4. Ednie LM, Jacobs MR, Appelbaum PC. Antianaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents. J Antimicrob Chemother 2002; 50:101-5.
5. Rubinstein E, Isturiz R, Standiford HC et al. Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies. Antimicrob Agents Chemother 2003; 47:1824-31.
6. Gerson SL, Kaplan SL, Bruss JB, Arellano FM, Halkin B, Kuter DJ. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother 2002; 46:2723-6.